Catalase C-262T polymorphism and risk of prostate cancer: Evidence from meta-analysis

Gene

Volumn 558, Issue 2, 2015, Pages 265-270

  Hu, Jieping ^a   Feng, Fupeng ^a   Zhu, Shimiao ^a   Sun, Libin ^a   Li, Gang ^a   Jiang, Ning ^a   Shang, Zhiqun ^a   Niu, Yuanjie ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Catalase; Meta analysis; Polymorphism; Prostate cancer

Indexed keywords

CATALASE; CATALASE C 262T; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; ETHNICITY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; META ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMATIC REVIEW; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; PROMOTER REGION; PROSTATE TUMOR; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CATALASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84922231964     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.01.005     Document Type: Article

References (22)

1. Ahn J.Y., Nowell S., McCann S.E., Yu J.H., Carter L., Lang N.P., Kadlubar F.F., Ratnasinghe L.D., Ambrosone C.B. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1217-1222.
2. Castaldo S.A., da Silva A.P., Matos A., Inacio A., Bicho M., Medeiros R., Alho I., Bicho M.C. The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible epistatic interaction in cervical cancer. Tumour Biol. 2014, 10.1007/s13277-014-2714-2.
3. Cheng T.Y., Barnett M.J., Kristal A.R., Ambrosone C.B., King I.B., Thornquist M.D., Goodman G.E., Neuhouser M.L. Genetic variation in myeloperoxidase modifies the association of serum alpha-tocopherol with aggressive prostate cancer among current smokers. J. Nutr. 2011, 141:1731-1737.
4. Choi J.Y., Neuhouser M.L., Barnett M., Hudson M., Kristal A.R., Thornquist M., King I.B., Goodman G.E., Ambrosone C.B. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1115-1120.
5. Christiansen L., Petersen H.C., Bathum L., Frederiksen H., McGue M., Christensen K. The catalase -262C/T promoter polymorphism and aging phenotypes. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:B886-B889.
6. Crawford A., Fassett R.G., Geraghty D.P., Kunde D.A., Ball M.J., Robertson L.K., Coombes J.S. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 2012, 501:89-103.
7. Ding G.X., Liu F., Shen B.X., Feng C.C., Xu J.F., Ding Q. The association between polymorphisms in prooxidant or antioxidant enzymes (myeloperoxidase, SOD2, and CAT) and genes and prostate cancer risk in the Chinese population of Han nationality. Clin. Genitourin. Cancer 2012, 10:251-255.
8. Eeles R., Goh C., Castro E., Bancroft E., Guy M., Al Olama A.A., Easton D., Kote-Jarai Z. The genetic epidemiology of prostate cancer and its clinical implications. Nat. Rev. Urol. 2014, 11:18-31.
9. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
10. Geybels M.S., van den Brandt P.A., van Schooten F.J., Verhage B.A. Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 2014, 10.1158/1055-9965.EPI-14-0968.
11. Glorieux C., Dejeans N., Sid B., Beck R., Calderon P.B., Verrax J. Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem. Pharmacol. 2011, 82:1384-1390.
12. Glorieux C., Auquier J., Dejeans N., Sid B., Demoulin J.B., Bertrand L., Verrax J., Calderon P.B. Catalase expression in MCF-7 breast cancer cells is mainly controlled by PI3K/Akt/mTor signaling pathway. Biochem. Pharmacol. 2014, 89:217-223.
13. Goyal M.M., Basak A. Human catalase: looking for complete identity. Protein Cell 2010, 1:888-897.
14. Karunasinghe N., Han D.Y., Goudie M., Zhu S.T., Bishop K., Wang A., Duan H., Lange K., Ko S., Medhora R., Kan S.T., Masters J., Ferguson L.R. Prostate disease risk factors among a New Zealand cohort. J. Nutrigenet. Nutrigenomics 2012, 5:339-351.
15. Nadif R., Mintz M., Jedlicka A., Bertrand J.P., Kleeberger S.R., Kauffmann F. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic. Res. 2005, 39:1345-1350.
16. Plata Bello A., Concepcion Masip T. Prostate cancer epidemiology. Arch. Esp. Urol. 2014, 67:373-382.
17. Sacks H.S., Berrier J., Reitman D., Ancona-Berk V.A., Chalmers T.C. Meta-analyses of randomized controlled trials. N. Engl. J. Med. 1987, 316:450-455.
18. Taniguchi N., Konno S., Isada A., Hattori T., Kimura H., Shimizu K., Maeda Y., Makita H., Hizawa N., Nishimura M. Association of the CAT-262C>T polymorphism with asthma in smokers and the nonemphysematous phenotype of chronic obstructive pulmonary disease. Ann. Allergy Asthma Immunol. 2014, 113:31-36.
19. Tefik T., Kucukgergin C., Sanli O., Oktar T., Seckin S., Ozsoy C. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease. BJU Int. 2013, 112:E406-E414.
20. Tsai J.Y., Lee M.J., Chang M.D.T., Huang H. The effect of catalase on migration and invasion of lung cancer cells by regulating the activities of cathepsin S, L, and K. Exp. Cell Res. 2014, 323:28-40.
21. Warchol T., Lianeri M., Wudarski M., Lacki J.K., Jagodzinski P.P. Catalase-262C>T polymorphism in systemic lupus erythematosus in Poland. Rheumatol. Int. 2008, 28:1035-1039.
22. Zintzaras E., Ioannidis J.P. Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 2005, 28:123-137.